{"id":"https://openalex.org/W2184410091","doi":null,"title":"EFFECT OF ABOUTHIOULINE, A NOVEL DRUG WITH THERAPEUTIC POTENTIAL AS ANTITHYROID, ON SOME BIOCHEMICAL AND HEMATOLOGIC PARAMETERS IN MICE AND RATS","display_name":"EFFECT OF ABOUTHIOULINE, A NOVEL DRUG WITH THERAPEUTIC POTENTIAL AS ANTITHYROID, ON SOME BIOCHEMICAL AND HEMATOLOGIC PARAMETERS IN MICE AND RATS","publication_year":2015,"publication_date":"2015-02-06","ids":{"openalex":"https://openalex.org/W2184410091","mag":"2184410091"},"language":"en","primary_location":{"id":"pmh:oai:CiteSeerX.psu:10.1.1.552.6278","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.552.6278","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://faculty.ksu.edu.sa/hisham/Documents/PAPERS/ABL_Toxicity.pdf","raw_type":"text"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Hisham S. Abou-auda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28022161","display_name":"King Saud University","ror":"https://ror.org/02f81g417","country_code":"SA","type":"education","lineage":["https://openalex.org/I28022161"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Hisham S. Abou-auda","raw_affiliation_strings":["King saud univ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"King saud univ","institution_ids":["https://openalex.org/I28022161"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046561607","display_name":"Rafiq R.A. Abou-Shaaban","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rafiq R. A. Abou-shaaban","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.11030913,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10293","display_name":"Thyroid Disorders and Treatments","score":0.9613999724388123,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10293","display_name":"Thyroid Disorders and Treatments","score":0.9613999724388123,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.030899999663233757,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antithyroid-drugs","display_name":"antithyroid drugs","score":0.9629999995231628},{"id":"https://openalex.org/keywords/propylthiouracil","display_name":"propylthiouracil","score":0.8309999704360962},{"id":"https://openalex.org/keywords/methimazole","display_name":"methimazole","score":1.0},{"id":"https://openalex.org/keywords/preclinical-toxicology","display_name":"preclinical toxicology","score":0.6940000057220459},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.9290000200271606},{"id":"https://openalex.org/keywords/agranulocytosis","display_name":"agranulocytosis","score":0.9829999804496765},{"id":"https://openalex.org/keywords/serum-electrolytes","display_name":"serum electrolytes","score":0.7369999885559082},{"id":"https://openalex.org/keywords/blood-glucose","display_name":"blood glucose","score":0.6840000152587891},{"id":"https://openalex.org/keywords/thiourea-derivatives","display_name":"thiourea derivatives","score":0.6869999766349792},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.734000027179718}],"concepts":[{"id":"https://openalex.org/C2775960720","wikidata":"https://www.wikidata.org/wiki/Q377342","display_name":"Propylthiouracil","level":3,"score":0.9749583005905151},{"id":"https://openalex.org/C2776606491","wikidata":"https://www.wikidata.org/wiki/Q1365501","display_name":"Antithyroid agent","level":4,"score":0.7877153158187866},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6168111562728882},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5741091370582581},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5719527006149292},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5088725090026855},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.47536367177963257},{"id":"https://openalex.org/C2909564963","wikidata":"https://www.wikidata.org/wiki/Q1365501","display_name":"Antithyroid drugs","level":4,"score":0.4691433310508728},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4584304094314575},{"id":"https://openalex.org/C2781440808","wikidata":"https://www.wikidata.org/wiki/Q846316","display_name":"Aplastic anemia","level":3,"score":0.43859240412712097},{"id":"https://openalex.org/C2776652619","wikidata":"https://www.wikidata.org/wiki/Q16483","display_name":"Graves' disease","level":3,"score":0.2546481490135193},{"id":"https://openalex.org/C526584372","wikidata":"https://www.wikidata.org/wiki/Q16399","display_name":"Thyroid","level":2,"score":0.2019156813621521},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.19061866402626038}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:CiteSeerX.psu:10.1.1.552.6278","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.552.6278","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://faculty.ksu.edu.sa/hisham/Documents/PAPERS/ABL_Toxicity.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W147273853","https://openalex.org/W231528845","https://openalex.org/W1966500252","https://openalex.org/W1980407277","https://openalex.org/W1991473443","https://openalex.org/W2018341604","https://openalex.org/W2030122788","https://openalex.org/W2038624525","https://openalex.org/W2051760881","https://openalex.org/W2077156091","https://openalex.org/W2090730711","https://openalex.org/W2133201734","https://openalex.org/W2228653336","https://openalex.org/W2955504961","https://openalex.org/W3023517638"],"related_works":["https://openalex.org/W2071116023","https://openalex.org/W147273853","https://openalex.org/W2408860778","https://openalex.org/W2141299388","https://openalex.org/W7134238114","https://openalex.org/W2410556415","https://openalex.org/W2424752994","https://openalex.org/W109709611","https://openalex.org/W2467058847","https://openalex.org/W1901516800"],"abstract_inverted_index":{"Abouthiouline":[0,9,125,158],"(1-Cyclohexyl-3(3-quinolyl)-2-thiourea)":[1],"is":[2,159,173],"a":[3,160,166],"novel":[4],"compound":[5,27],"with":[6,48,73,165,175],"antithyroid":[7,163],"activity.":[8],"(ABL)":[10],"was":[11,65],"designed":[12],"based":[13],"on":[14,91,119,130],"structure-activity":[15],"relationships":[16],"(E-state":[17],"indexes)":[18],"aimed":[19],"at":[20],"reducing":[21],"the":[22,26,57,60],"antioxidant":[23],"properties":[24],"of":[25,30,36,51,63,114,153,169],"by":[28],"modification":[29],"acyclic":[31],"thiourylene":[32],"moiety.":[33],"Antioxidant":[34],"effects":[35,90,113,129],"currently":[37],"available":[38],"treatments":[39],"such":[40],"as":[41],"propylthiouracil":[42,116],"(PTU),":[43],"methimazole":[44,118],"(MTM)":[45],"are":[46,181],"associated":[47,174],"an":[49],"incidence":[50],"agranulocytosis":[52],"and":[53,69,71,101,117,122,138,142,177],"aplastic":[54],"anemia.":[55],"In":[56],"present":[58],"study,":[59],"preclinical":[61],"toxicology":[62],"ABL":[64,87],"determined":[66],"in":[67,97,109],"mice":[68],"rats":[70,110],"compared":[72],"two":[74],"reference":[75],"compounds,":[76],"namely,":[77],"propylthiouracil,":[78],"methimazole.":[79],"Following":[80],"short-term":[81],"administration":[82],"(7":[83],"days)":[84,108],"to":[85],"mice,":[86],"had":[88,126],"minimal":[89],"biochemical":[92],"parameters,":[93],"although":[94],"significant":[95,112],"reductions":[96],"both":[98],"total":[99,134],"protein":[100],"albumin":[102],"were":[103,144],"noted.":[104],"Long-term":[105],"studies":[106,180],"(30":[107],"revealed":[111],"Abouthiouline,":[115],"serum":[120],"electrolyte":[121],"glucose":[123],"levels.":[124],"no":[127],"detrimental":[128],"hematologic":[131,170],"parameters.":[132],"However,":[133],"WBC":[135],"count":[136],"(propylthiouracil)":[137],"neutrophil":[139],"levels":[140],"(propylthiouracil":[141],"methimazole)":[143],"significantly":[145],"decreased":[146],"among":[147],"other":[148],"treatment":[149],"groups.":[150],"The":[151],"results":[152],"this":[154],"investigation":[155],"suggest":[156],"that":[157,172],"promising":[161],"new":[162],"therapy":[164],"reduced":[167],"risk":[168],"toxicity":[171],"PTU":[176],"MTM.":[178],"Further":[179],"warranted":[182]},"counts_by_year":[],"updated_date":"2026-08-26T07:47:46.906454","created_date":"2025-10-27T00:00:00"}